37th AGM: 3 resolutions passed unanimously; MD re-appointed

Ganga Pharmaceuticals held its 37th AGM on September 26, 2026, concluding in 25 minutes. All 3 ordinary resolutions passed with 100 percent votes in favour and zero against. These were: adoption of audited financial statements for FY ended March 31, 2026; re-appointment of Mr Sanjay Kulkarni as Director (retiring by rotation); and re-appointment of Mr Bharat Brijmohan Sharma as Managing Director and CEO. Of 364 shareholders on record, 14 voted covering 54.16 percent of outstanding shares. Promoters polled 100 percent of holdings; public participation was 6.62 percent.